Significance of RGD loop and C-terminal domain of echistatin for recognition of αIIbβ3 and αvβ3 integrins and expression of ligand- induced binding site

Blood

Volumn 90, Issue 4, 1997, Pages 1565-1575

  Marcinkiewicz, Cezary ^a   Vijay Kumar, Senadhi ^a   McLane, Mary Ann ^a   Niewiarowski, Stefan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHISTATIN; INTEGRIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 0030750415     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1565.1565_1565_1575     Document Type: Article

References (50)

1. Huang T-F, Holt JC, Lukasiewicz H. Niewiarowski S: Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. J Biol Chem 262:16157, 1987
2. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA: Platelet glycoprotein IIb-IIIa antagonists from snake venom: Evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 87:2471, 1990
3. Gould RJ, Polokoff MA, Friedman PA, Huang T-F, Holt JC, Cook JJ, Niewiarowski S: Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195:168, 1990
4. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ: Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptor. Semin Hematol 31:289, 1994
5. Can ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA: Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem 263:19827, 1988
6. Garsky VM, Lumma PK, Freidinger RM, Pitzenberger SM, Randall WC, Veber DF, Gould RJ, Friedman PA: Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: Synthesis and biological activity of selected analogous. Proc Natl Acad Sci USA 86:4022, 1989
7. Cooke RM, Carter BG, Martin DMA, Murray-Rust P, Weir MP: Nuclear magnetic resonance studies of the snake toxin echistatin. Eur J Biochem 202:323, 1991
8. Cooke RM, Carter BG, Murray-Rust P, Hartshorn MJ, Herzyk P, Hubbard RE: The solution structure of echistatin: Evidence for disulfide bound rearrangement in homologous snake toxin. Prot Eng 5:473, 1992
9. Saudek V, Atkinson RA, Pelton JT: Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30:7369, 1991
10. 1H NMR studies of echistatin in solution. Sequential resonance assignments and secondary structure. Eur J Biochem 202:315, 1991
11. Calvete JJ, Wang Y, Mann K, Schäfer W, Niewiarowski S, Stewart GJ: The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett 309:316, 1992
12. Gray WR: Echistatin disulfide bridges: Selective reduction and linkage assignment. Prot Sci 2:1749, 1993
13. Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF: Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 268:1958, 1993
14. Pfaff M, McLane MA, Beviglia L, Niewiarowski S, Timpl R: Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins αIIbβ3, αvβ3 and α5β1 and in cell adhesion inhibition. Cell Adhes Commun 2:491, 1994
15. Savage B, Marzec UM, Chao BH, Harker LA, Marganoe JM, Ruggeri ZM: Binding of the snake venom-derived proteins applagin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb/IIIa complex inhibits receptor function. J Biol Chem 265:11766, 1990
16. Shebuski RJ, Ramjit DR, Sitko GR, Lumma PK, Garsky VM: Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatus. Thromb Haemost 64:576, 1990
17. Sato M, Sardana K, Grasser WA, Garsky VM, Murray JM, Gould RJ: Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713, 1990
18. Juliano D, Wang Y, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S: Disintegrins interaction with αvβ3 integrin on human umbilical vein endothelial cells. Expression of ligand-induced binding site on β3 subunit. Exp Cell Res 225:132, 1996
19. McLane MA, Vijay-Kumar S, Marcinkiewicz C, Calvete JJ, Niewiarowski S: Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of αIIbβ3 and αvβ3 integrins. FEBS Lett 391:139, 1996
20. McLane MA, Kowalska MA, Silver L, Shattil SJ, Niewiarowski S: Interaction of disintegrins with the αIIbβ3 receptors on resting and activated human platelets. Biochem J 301:429, 1994
21. Du X, Gu M, Weisel MW, Nagasawami C, Bennett JS, Bowditch R, Ginsberg MH: Long range propagation of conformational changes in integrin αIIbβ3. J Biol Chem 268:23087, 1993
22. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S: Immunological characterization of eristostatin and echistatin binding sites on αIIbβ3 and αvβ3 integrins. Biochem J 317:817, 1996
23. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo I: A GPIIb-IIIa specific integrin antagonist from venom of Sistrurus M. Barbouri. J Biol Chem 266:9359, 1991
24. Coller B: A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 76:101, 1985
25. Frelinger AL III, Cohen I, Smith MA, Roberts J, Lam SCT, Ginsberg MH: Selective inhibition of integrin function by antibodies specific for ligand occupied receptor conformers. J Biol Chem 256:6346, 1990
26. Honda S, Tomiyama Y, Pelletier AJ, Annis D, Honda Y, Orchekowski R, Ruggeri ZM, Kunicki TJ: Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin β3 subunit. J Biol Chem 270:11947, 1995
27. Cheresh DA, Harper JR: Arg-gly-asp recognition by a cell adhesion receptor requires its 130 kDa α subunit. J Biol Chem 262:1434, 1987
28. Newman PJ, Alien RW, Kahn RA, Kunicki TJ: Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody AP-3. Blood 65:227, 1985
29. O'Toole TE, Loftus JC, Plow EF, Glass A, Harper JR, Ginsberg MH: Efficient surface expression of platelet GPIIb-IIIa requires both subunits. Blood 74:14, 1989
30. O'Toole TE, Loftus JC, Du X, Glass A, Ruggeri ZM, Shattil SJ, Plow EF, Ginsberg MH: Affinity modulation of the αIIbβ3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1:883, 1990
31. Marcinkiewicz C, Rosenthal LA, Marcinkiewicz MM, Kowalska MA, Niewiarowski S: One-step affinity purification of recombinant αvβ3 integrin from transfected cells. Prot Express Purif 8:68, 1996
32. Shattil SJ, Canningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307, 1987
33. 125I-containing acylating agent. Biochem J 133:529, 1973
34. Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ: Antiheparin proteins secreted by human platelets, purification and characterization and radioimmunoassay. Blood 53:47, 1979
35. Cook JJ, Trybulec M, Lasz EC, Khan S, Niewiarowski S: Binding of glycoprotein IIIa-derived peptide 217-231 to fibrinogen and von Willebrant factors and its inhibition by platelet glycoprotein IIb-IIIa complex. Biochim Biophys Acta 1119:312, 1992
36. Jones TA: A graphic model building and refinement system for macromolecule. J Appl Crystallogr 11:268, 1978
37. Powell MJD: Restart procedures for the conjugate gradient method. Math Prog 12:241, 1977
38. Brünger AT, Krukowski A, Erickson JW: Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Cryst A46:585, 1990
39. Lu X, Rahman S, Kakkar VV, Authi KS: Substitution of proline 42 to alanine and methionine 46 to asparagine around the RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elegantin. J Biol Chem 271:289, 1996
40. Scaloni A, DiMartino E, Miraglia N, Pelagalli A, Della Morte R, Staiano N, Pucci P: Amino acid sequence and molecular modeling of glycoprotein IIb-IIIa and fibronectin receptor iso-antagonist from Tr.elegans venom. Biochem J 319:775, 1996
41. Seymour JL, Henzel WJ, Nevins B, Stults JT, Lazarus RA: Decorsin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 265:10143, 1990
42. Krezel AM, Wagner G, Seymour-Ulmer J, Lazarus RA: Structure of the RGD protein decorsin: Conserved motif and distinct function in leech proteins that affect blood clotting. Science 264:1944, 1994
43. McLane MA, Gabbeta J, Rao AK, Beviglia L, Lazarus RA, Niewiarowski S: A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin on platelet function. Thromb Haemost 74:1316, 1995
44. Wright PS, Saudek V, Owen TJ, Harbeson SL, Bitonti AJ: An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV. Biochem J 293:263, 1993
45. Chen YL, Huang TF, Chen SW, Tsai IH: Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species. Biochem J 305:513, 1995
46. Senn H, Klaus W: The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GPIIb-IIIa receptor. J Mol Biol 232:907, 1993
47. Savage B, Ruggeri ZM: Selective recognition of adhesive sites in surface bound fibrinogen by glycoprotein IIb-IIIa on non activated platelets. J Biol Chem 266:11227, 1991
48. Kouns WC, Kirchofer D, Hadvary P, Edenhofer A, Weller T, Pfenninger G, Baumgartner HR, Jennings LK, Steiner B: Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor. Blood 80:2539, 1992
49. Kouns WC, Weller T, Hadvary P, Jennings LK, Steiner B: Identification of a peptidomimetic inhibitor with minimal effects on the conformation of GPIIb-IIIa. Blood 80:165a, 1992 (abstr, suppl 1)
50. Pelletier AJ, Kunicki TJ, Quaranta V: Activation of the integrin αvβ3 involves a discrete cation-binding site that regulates conformation. J Biol Chem 271:1364, 1996